This overview focuses on the recent developments in the safety and efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) on established indications, namely contraception ...

A study found an “unexpected” association between the use of an intrauterine system (IUS), also known as an hormonal coil, and an increased risk of the cancer in women aged 15 to 49.

A comprehensive overview of Cochrane reviews highlighted that the levonorgestrel-releasing intrauterine system (LNG-IUS) is the most effective first-line treatment for reducing menstrual blood ...